Professor and Vice Dean, College of Medicine, China Medical University, Taichung, Taiwan
Director, Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan
2008/11-, Honorary Faculty of Stress, Psychiatry and Immunology Laboratory (SPI-Lab), Institute of Psychiatry-King's College London
1999/5-2002/3, Attending physician, Department of Psychiatry, Wan Fang Medical Centre & Taipei Medical University Hospital
Education & Training
1988-1995, M.D., Kaohsiung Medical College, Kaohsiung, Taiwan
1995-1999, Chief Resident and Resident, Taipei City Psychiatric Centre
2005-2008, PhD, Institute of Psychiatry, King’s College London, UK
2016, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): Early Career Award
2013, Psychopharmacology Award from the British Association for Psychopharmacology (UK)
2012 and 2010, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): New Investigator Award
2011, Thomson Reuters Research Front Award
2010, Ta-You Wu Memorial Award (國科會吳大猷獎), National Science Council, Taiwan
Biological mechanisms and clinical subtyping for comorbidity of chronic pain and depression: The molecular approach of central sensitization. (2017-2020, MOST106-2314-B-039-027-MY3)
N-3 fatty acids as the first-line antidepressant therapy: From biomarkers to clinical subtypes (2016-2018, 3-Year Innovative Research Grant (IRG) of Integrated Research Grants in Health and Medical Sciences from National Health Research Institutes NHRI-EX105-10528NI)
Pharmacogenomics of n-3 polyunsaturated fatty acids treatment for major depressive disorder: Genome-wide associations. (2014-2017, Ministry of Science and Technology)
Major depression and omega-3 fatty acids: From cellular mechanisms to clinical implications (2014-2016, NCBR [National Centre for Research and Development, Poland] and Taiwan Ministry of Science and Technology Joint Research Projects)
Neuropsychobiology of Brain Theta-burst Stimulation: A Mind-body Interface for Depression (2012-2014, Innovative Research Grant (IRG) of Integrated Research Grants in Health and Medical Sciences from National Health Research Institutes NHRI-EX101-10144NI)
Committee & Membership
Member of Board of Directors, the International Society for the Study of Fatty Acids and Lipids (ISSFAL) (2016-2020)
Council Board Member of the International Society for Nutritional Psychiatry Research (ISNPR) (since 2013)
President of Taiwan Society for Nutritional Psychiatry Research (TSNPR) (since 2016)
Lin PY, Chang CH, Chongc MFF, Chen H, Su KP*. Polyunsaturated fatty acids in perinatal depression: A systematic review and meta-analysis. Biological Psychiatry (Accepted) doi: 10.1016/j.biopsych.2017.02.1182. [Epub ahead of print]
Chang JPC, Su KP, Mondelli V, Pariante C. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology (Accepted) doi: 10.1038/npp.2017.160. [Epub ahead of print]
Sarris J, Logan A, Akbaraly T, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. Nutritional Medicine as Mainstream in Psychiatry. Lancet Psychiatry 2015 Mar; 2(3): 271-4.
Chang JPC, Chang SS, Yang HT, Palani M, Chen CP, Su KP*. Polyunsaturated fatty acids levels in patients with cardiovascular diseases with and without depression. Brain, Behavior, and Immunity 2015 Feb; 44: 28-31.
Sarris J, Logan A, Akbaraly T, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry 2015 Oct; 14(3): 370-1.
Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JPC, Huang CL, Chang HC, Pariante CM. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression Results from a randomized, controlled trial. Biological Psychiatry 2014 Oct 1; 76(7): 559-66.
Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, Su KP*. Are omega-3 fatty acids anti-depressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Molecular Psychiatry 2012 Dec; 17(12): 1161-3.
Lu DY, Tsao YY, Leung YM, Su KP*. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: Implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 2010 Oct; 35(11): 2238–2248. (*Correspondence).
Lin PY, Huang SY, Su KP*. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 2010; 68(2):140-147. (*Correspondence).
Su KP, Huang SY, Peng CY, Lai CH, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclo-oxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry 2010; 67(6): 550-557.
Taiwanese Society for Nutritional Psychiatry Research 台灣營養精神醫學研究學會 email@example.com